Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 339

• Price / Volume Information    Yesterday's Closing Price: $5.27 Daily Weekly Monthly 20 Day Moving Average: 53,738 shares Shares Outstanding: 4.47 (millions) Market Capitalization: $23.57 (millions) Beta: 1.50 52 Week High: $8.40 52 Week Low: $2.81 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.67% -4.07% 12 Week -24.96% -20.08% Year To Date -21.20% -17.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 hbio@threepa.com http://www.harvardbioscience.com

• General Corporate Information    Officers John Duke - Chief Executive Officer and Director Mark Frost - Chief Financial Officer and Treasurer Katherine A. Eade - Director Robert Gagnon - Director Seth Benson - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP.) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (PBSC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906204 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/11/26 Share - Related Items Shares Outstanding: 4.47 Most Recent Split Date: 3.00 (0.10:1) Beta: 1.50 Market Capitalization: $23.57 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.72 Price/Cash Flow: 0.45 Price / Sales: 0.27 EPS Growth vs. Year Ago Period: -125.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -3.34% vs. Previous Quarter: 15.27% ROE 12/31/25 - -19.54 09/30/25 - -2.29 06/30/25 - -5.64 ROA 12/31/25 - -3.59 09/30/25 - -0.68 06/30/25 - -2.15 Current Ratio 12/31/25 - 2.20 09/30/25 - 0.81 06/30/25 - 0.81 Quick Ratio 12/31/25 - 1.25 09/30/25 - 0.41 06/30/25 - 0.41 Operating Margin 12/31/25 - -3.30 09/30/25 - -0.71 06/30/25 - -2.53 Net Margin 12/31/25 - -65.51 09/30/25 - -61.62 06/30/25 - -64.68 Pre-Tax Margin 12/31/25 - -66.30 09/30/25 - -61.34 06/30/25 - -64.17 Book Value 12/31/25 - 3.07 09/30/25 - 3.16 06/30/25 - 3.56 Inventory Turnover 12/31/25 - 1.68 09/30/25 - 1.67 06/30/25 - 1.62 Debt-to-Equity 12/31/25 - 2.61 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - 72.31 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©